Archway Health Partners with Coalition of Leading Oncology Groups

FOR IMMEDIATE RELEASE

Media Contact: Jamie Christensen email: jchristensen@archwayha.com

Boston, MA (June 30, 2016)

Archway Health announced today that it has entered into an innovative affiliation arrangement with a leading coalition of oncology medical groups for the purpose of developing superior tools and services to help practices build and manage oncology bundled payment programs. In addition to Archway, the coalition includes West Cancer Center, Memphis Tennessee; Center for Cancer and Blood Disorders, Fort Worth, Texas; Northwest Medical Specialties, Tacoma, Washington; and Cancer Center Business Development Group, Bedford, New Hampshire.

The goal of the affiliation is to combine Archway’s expertise in bundled payment program design, analytics, and management with the clinical and oncology care management expertise of these highly regarded, high quality practices. Together these organizations are developing a comprehensive approach to managing cancer care and tracking costs within the Medicare Oncology Care Model (OCM), as well as working to develop and manage commercial oncology bundled payment contracts. The tools and services they are building include detailed claims data analytics, quality performance benchmarking, opportunity and risk assessments, care model design, performance tracking dashboards, and patient tracking tools.

“We are very excited to be working with such a high quality, sophisticated coalition of oncology practices," said Dave Terry, Archway’s CEO. “The Archway model is to combine our expertise in building and managing bundled payment programs with the clinical expertise of specialists who are developing new and innovative ways to improve patient care. The oncology groups in the coalition have been pioneers in the Oncology Medical Home model for years, and we’re looking forward to learning from their experience and collaborating to develop the best approaches to improving care and reducing costs for patients with cancer.”

“We did an extensive search to find the right bundled payment partner and were very impressed with Archway Health,” said Barry Russo, Chief Executive Officer, The Center for Cancer and Blood Disorders. “The Archway team has been working in all the CMS bundled payment programs since they started in 2011, which gives them market-leading experience in this area. Their analytics capabilities, deep knowledge of the program intricacies, and experience helping specialty groups succeed within these programs are unique in the market. We were also impressed with their sincere interest in combining our expertise with theirs. We’re very excited to be working together.”

For additional information please contact Jamie Christensen.

About Archway Health

Archway works with providers to design and execute care and risk management programs that drive success in bundled payment contracts. Archway is currently working with dozens of providers across the country that are participating in the CMS BPCI, CJR, and OCM programs, as well as with commercial payers who are pursuing bundled payment initiatives. To support these programs, Archway works with providers to analyze their opportunities and risks and to deploy Archway’s comprehensive platform of analytics, patient tracking tools, and advisory services to ensure their success in bundled payments. Currently Archway is helping specialty practices more than triple their revenue per bundled payment patient.

About Oncology Bundled Pricing Coalition

The purpose of the Oncology Bundled Pricing Coalition is to develop a framework and methodology for providing oncology services at rates alternative to traditional fee-for-service, such as bundled prices. The coalition practices are all participants in the CMMI Oncology Care Model program (OCM). Coalition members include West Cancer Center, Memphis Tennessee; Center for Cancer and Blood Disorders, Fort Worth, Texas; Northwest Medical Specialties, Tacoma, Washington; and Cancer Center Business Development Group, Bedford, New Hampshire.